It is very uncertain whether nasogastric changes mortality compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes organ failure (single or multiple) compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes rate of infection (local or systemic) compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes success rate of the procedure compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes complications associated with the procedure compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes surgical intervention compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether nasogastric changes requirement for parenteral nutrition compared with nasojejunal tube feeding (very low certainty).
It is very uncertain whether erythromycin plus nasogastric tube lavage changes all‐cause mortality compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).
It is very uncertain whether erythromycin plus nasogastric tube lavage changes NSAEs compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).
It is very uncertain whether erythromycin plus nasogastric tube lavage changes rebleeding compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether erythromycin plus nasogastric tube lavage changes visualisation of gastric mucosa compared with metoclopramide plus nasogastric tube lavage (very low certainty).
The review found no eligible studies for this question.